Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication

Lior Greenbaum, Rael D. Strous, Kyra Kanyas, Yifat Merbl, Anat Horowitz, Osnat Karni, Elena Katz, Moshe Kotler, Tsviya Olender, Smita N. Deshpande, Doron Lancet, Edna Ben-Asher, Bernard Lerer

Pharmacogenetics and Genomics, 2007. DOI 10.1097/fpc.0b013e32800ffbb4

Has this study been replicated?

The atlas records 1 replication of this study. Recorded outcomes: 1 mixed. The earliest on record is from 2008.

Replications

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3′-untranslated region, Greenbaum et al. (2008). The Pharmacogenomics Journal. Outcome recorded: mixed. Taken together, the findings of the current study support the association of RGS2 with AIP and focus on a possible protective effect of the minor G allele of SNP rs4606. Outcome read from the abstract. View paper

Cite this record

Greenbaum, L., Strous, R. D., Kanyas, K., Merbl, Y., Horowitz, A., Karni, O., Katz, E., Kotler, M., Olender, T., Deshpande, S. N., Lancet, D., Ben-Asher, E., & Lerer, B. (2007). Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenetics and Genomics, 17(7), 519–528. https://doi.org/10.1097/fpc.0b013e32800ffbb4

Other studies in the atlas

Failed replications · Successful replications · All browse pages